Adenocarcinoma of pancreas
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Four (hsa-mir-126, hsa-mir-3613, hsa-mir-424, and hsa-mir-4772) out of 17 differentially expressed miRNAs were associated to the OS of patients with PAAD.
|
31297864 |
2019 |
Adenocarcinoma of pancreas
|
0.020 |
Biomarker
|
disease |
BEFREE |
Taken together, these findings suggested that the five-miRNA signature (hsa-miR-203, hsa-miR-424, hsa-miR-1266 hsa-miR-1293, and hsa-miR-4772) could be used as a prognostic marker for pancreatic adenocarcinoma.
|
29769534 |
2018 |
Pleural Effusion, Malignant
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Downregulation of miR-4772-3p promotes enhanced regulatory T cell capacity in malignant pleural effusion by elevating Helios levels.
|
31725455 |
2019 |
MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The verified downregulation of miR-4772-3p was inversely related to the Helios Tregs frequency and Helios expression in the MPE.
|
31725455 |
2019 |
Malignant tumor of colon
|
0.010 |
Biomarker
|
disease |
BEFREE |
Serum exosomal miR-4772-3p is a predictor of tumor recurrence in stage II and III colon cancer.
|
27788488 |
2016 |
Neoplasms
|
0.010 |
AlteredExpression
|
group |
BEFREE |
As a predictor for tumor recurrence, ROC analysis revealed the AUC (95% CI) was 0.72 (0.59-0.85, P=0.001) for lower level of miR-4772-3p compared to 0.63 (0.51-0.75, P=0.062) for tumor site and 0.65 (0.51-0.78,P=0.034) for lymph node status.
|
27788488 |
2016 |
Stage III Colon Cancer
|
0.010 |
Biomarker
|
disease |
BEFREE |
Reduced expression of serum exosomal miR-4772-3p is a prognostic biomarker for tumor recurrence in stage II and stage III colon cancer patients.
|
27788488 |
2016 |
Recurrent tumor
|
0.010 |
AlteredExpression
|
phenotype |
BEFREE |
Among 66/84 patients who received FOLFOX adjuvant therapy, 9/10 (90%) patients with a lower level and 10/56 (18%) patients with a higher level of miR-4772-3p had tumor recurrence (P<0.001).
|
27788488 |
2016 |
Colon Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Serum exosomal miR-4772-3p is a predictor of tumor recurrence in stage II and III colon cancer.
|
27788488 |
2016 |
Stage III Colon Cancer AJCC v7
|
0.010 |
Biomarker
|
disease |
BEFREE |
Reduced expression of serum exosomal miR-4772-3p is a prognostic biomarker for tumor recurrence in stage II and stage III colon cancer patients.
|
27788488 |
2016 |
Stage III Colon Cancer AJCC v8
|
0.010 |
Biomarker
|
disease |
BEFREE |
Reduced expression of serum exosomal miR-4772-3p is a prognostic biomarker for tumor recurrence in stage II and stage III colon cancer patients.
|
27788488 |
2016 |
Septicemia
|
0.010 |
Biomarker
|
disease |
BEFREE |
After qRT-PCR validation, microRNA miR-150 and miR-4772-5p-iso were able to discriminate between patients who have systemic inflammatory response syndrome and patients with sepsis.
|
24146790 |
2013 |
Systemic Inflammatory Response Syndrome
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
After qRT-PCR validation, microRNA miR-150 and miR-4772-5p-iso were able to discriminate between patients who have systemic inflammatory response syndrome and patients with sepsis.
|
24146790 |
2013 |
Sepsis
|
0.010 |
Biomarker
|
disease |
BEFREE |
After qRT-PCR validation, microRNA miR-150 and miR-4772-5p-iso were able to discriminate between patients who have systemic inflammatory response syndrome and patients with sepsis.
|
24146790 |
2013 |